The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and adolescent girls. The drug is made by British pharmaceutical company GSK.

Background. Klebsiella pneumoniae is a common colonizer of the gastrointestinal tract of humans, companion animals, and livestock. To better understand potential contributions of foodborne K.

The treatment has been shown to be active against third generation cephalosporin-resistant Enterobacterales species. Orlynvah combines sulopenem etzadroxil, a penem antibacterial drug, and probenecid, ...

(RTTNews) - Iterum Therapeutics plc (ITRM) Friday announced that the U.S. Food and Drug Administration (FDA) has approved Iterum's new drug application for Orlynvah (sulopenem etzadroxil and ...

Researchers have concocted a cocktail of bacteria-fighting viruses with the potential to successfully treat antibiotic-resistant Klebsiella pneumoniae infections. In a recent study, researchers led by ...

GSK said the U.S. Food and Drug Administration approved its Blujepa oral antibiotic for the treatment of female adults and children with uncomplicated urinary tract infections. The pharmaceutical ...